Arkolith/Insider Trading/CNSP/Form 4

Downs Christopher

Chief Financial OfficerCNS Pharmaceuticals, Inc. (CNSP) · full profile →Form 4 · filed Aug 23, 2023
Net Buying
Open-Market Buys
$34K
Open-Market Sells
$0
Net Open-Market Flow
$34K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2023Buy(P)27K$1.27$34K37K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-23-006001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML